Tag: AB101

July 25, 2017

AntriaBio Announces First Patient Dosed in Clinical Study

AntriaBio announced the dosing of the first patient in their Phase 1 first-in-human clinical trial of its lead product candidate,...
June 5, 2017

AntriaBio Files Investigational NDA for AB101

AntriaBio filed an Investigational New Drug application with the FDA for their basal insulin treatment for diabetes mellitus patients. A...
May 1, 2017

AntriaBio Looks for Prosciento to Conduct Phase I Clinical Trial

AntriaBio began engaging Prosciento to conduct a clinical study of AB101 for patients with diabetes mellitus.